The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Transaction #1010 · Form 4 · 0001477932-25-007585

VOLITIONRX LTD · Purchase · Common Stock

VOLITIONRX LTD · Transacted October 14, 2025 · Filed October 15, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for VOLITIONRX LTD records a purchase involving Common Stock on October 14, 2025. The reported quantity was 48,076. The filing date is October 15, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0000093314
Security type
Non-derivative
Acquisition type
Purchase · Code P
Quantity acquired
48,076
Reported price
0.51
Reference value
24,518.76
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
1,535,458
Ownership description
Not reported
SEC acceptance time
Oct 15, 2025, 4:05 PM EDT
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

VNRX · NYSE · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer. The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.